Brief: Sandboxaq And Maplight Therapeutics Announce Collaboration To Discover And Develop Novel CNS Therapies
16/12/2025 12:06
Dec 16 (Reuters) - Maplight Therapeutics Inc MPLT.O: SANDBOXAQ AND MAPLIGHT THERAPEUTICS ANNOUNCE STRATEGIC COLLABORATION TO DISCOVER AND DEVELOP NOVEL CNS THERAPIES MAPLIGHT THERAPEUTICS INC - SANDBOXAQ ELIGIBLE FOR UP TO $200 MILLION IN MILESTONE PAYMENTS Source text: ID:nGNX5q2TV7 Further company coverage: MPLT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MapLight Therapeutics
See all newsUS and German scientists win Nobel medicine prize for work on light and brain (updated)
U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, Intuit
MapLight's schizophrenia drug fails once-daily test, shares plunge
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals
U.S. STOCKS ON THE MOVE-Abbvie, AMC, Getty